Camptosar 20 mg/mL

Camptosar 20 mg/mL is an injectable solution containing irinotecan hydrochloride, used for specific medical treatments. This single-dose vial is designed for intravenous administration and is manufactured by Pharmacia & Upjohn Company LLC in the USA.

Camptosar 20 mg/mL is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Camptosar used for?' and the answer lies in its role as an antineoplastic agent, targeting specific cancer cells to slow their growth.

Common effects of Camptosar 20 mg/mL may include nausea, vomiting, and diarrhea. Some patients might experience fatigue or changes in blood cell counts. These effects can vary widely among individuals, and it's important to discuss any concerns with a healthcare provider.

Handling Camptosar 20 mg/mL requires careful attention to safety protocols. It should only be administered by healthcare professionals trained in the use of chemotherapy agents. Proper disposal of the vial and any unused solution is crucial to prevent accidental exposure.

Camptosar 20 mg/mL may interact with other medications, including those that affect liver enzymes. Alcohol and certain over-the-counter drugs might also influence its effectiveness or increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.